If your email client cannot read HTML emails, please visit our website

IMPORTANT E-MAIL DELIVERY INFORMATION: In order to view our newsletters in their entirety, please add our email address, news@johnshopkins.6cp.com, to your Contact List, Safe List or Address Book. This action should also ensure eViralHepatitis Review emails go directly to your Inbox.

Please do not reply to this email. To change/update your email address, please visit here.

Unsubscribe from this list.
Download PDF
eViralHepatitis Review eViralHepatitis Review
HOME NEWSLETTER
ARCHIVE
CME
INFORMATION
PROGRAM
DIRECTORS
EDIT
PROFILE
RECOMMEND TO
A COLLEAGUE

 

 

VOLUME 5 - ISSUE 6

LISTEN TO PODCAST

DOWNLOAD PODCAST

 

 

POST TEST

POST TEST

 

 

Clinical Insights: HCV and Substance Use Disorder

 

In our second newsletter/podcast pair on Advances in HBV Therapies, our post-assessment showed an increase of 8% following the education. We will report the results of issues 5 and 6 in an upcoming podcast.

Our guest authors are Andrew Talal, MD, MPH, Professor of Medicine and Richard Blondell, MD, Professor of Family Medicine at the University at Buffalo, State University of New York.
 

After participating in this activity, the participant will demonstrate the ability to:
  • Describe the recommendations for hepatitis C screening in persons with substance use disorders.
  • Identify the most prevalent risk factors for hepatitis C in this population.
  • Describe the correlation between addressing substance use disorders and receiving hepatitis C treatment. 

Guest Faculty Disclosure
Dr. Talal disclosed that he has received research funding from Abbott Laboratories, AbbVie, Inc., Gilead Sciences, Inc., and Merck & Co., Inc., and that he has served as a consultant for Abbott Laboratories and Merck & Co., Inc. Dr. Blondell indicated that he has no financial interests or relationships with a commercial entity whose products or services are relevant to the content of this presentation.

Unlabeled/Unapproved Uses
Dr. Talal and Dr. Blondell have indicated that there will be no references to unlabeled or unapproved uses of drugs or products. 

 

MEET THE AUTHORS

 

 

 

 

Andrew H. Talal, MD, MPH
Professor of Medicine
Director, Center for Clinical Care and Research in Liver Disease
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine
University at Buffalo
Buffalo, New York

Richard Blondell, MD
Professor of Family Medicine
Vice Chair for Addiction
Department of Family Medicine
University at Buffalo,
State University of New York
Buffalo, New York

 

 


Release Date: Expiration Date:
August 11, 2017 August 10, 2019

 

 

 

 

OTHER RESOURCES

 

 

 

Download the podcast transcript

Go to the companion newsletter

 

 

 

 


PROGRAM DIRECTORS

Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and
Gastroenterology/Hepatology

Johns Hopkins University School of Medicine
Baltimore, Maryland

Raymond T. Chung, MD
Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar

Massachusetts General Hospital
Harvard Medical School

Boston, Massachusetts

Taryn Haselhuhn, BA, BSN, MSN, CRNP
Nurse Practitioner
Johns Hopkins Hospital
Baltimore, Maryland

 

 

 

 

CME/CE INFORMATION

 

 

ACCREDITATION STATEMENT
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

CREDIT DESIGNATION STATEMENT
Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
eNewsletter: This 1.0 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 newsletters in this program.

POLICY ON SPEAKER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.

 

INTERNET CME/CE POLICY

DISCLAIMER STATEMENT

STATEMENT OF RESPONSIBILITY

STATEMENT OF NEED
INTENDED AUDIENCE

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS

HARDWARE & SOFTWARE REQUIREMENTS

COMPLETE CME INFORMATION

 

 

 

All rights reserved - The Johns Hopkins University School of Medicine. Copyright 2017.

This activity was developed in collaboration with DKBmed.